Helps clinicians and physicians PREdict better genetic diseases
Sophia Genetics has raised €212M across 5 funding rounds from 8 investors, most recently a Series D+ round in Oct 2020. Based in Saint-Sulpice, Switzerland; founded 2011; active in Software and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2020-10-01 | Series D+ | €94M | aMoon Fund | View deal → |
| 2019-01-01 | Series D+ | €67M | Balderton Capital | View deal → |
| 2017-07-14 | Series D+ | €26M | 360 Capital Partners,Alychlo,Balderton Capital,Invoke Capital Partners | View deal → |
| 2015-12-01 | Series C | €14M | — | View deal → |
| 2014-07-01 | Series B | €10M | Endeavour Vision,Invoke Capital,Swisscom | View deal → |
